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TRIGGERING OF THE CD44 ANTIGEN ON T LYMPHOCYTES PROMOTES T 
CELL ADHESION THROUGH THE LFA-1 PATHWAY1
GERRIT KOOPMAN,* YVETTE v a n  KOOYK,' MICHAEL de GRAAFF,* CHRIS J. L. M. MEYER,*
CARL G. FIGDOR,+ a n d  STEVEN T. PALS2*
Fro m  the *D epartm ent of Pathology, F re e  U n iv e rs ity, a n d  t h e +D iv is io n  of Im m u n o lo g y , T h e  N e th e rla n d s C a n c e r  Institute,
A m sterdam , T h e  N e th e rla n d s
The CD44 molecule, a molecule which has been 
previously known as Hermes, Pgp-1, extracellular 
matrix receptor III, and In(Lu)-related p80, is cur­
rently thought to be involved in several steps of 
normal immune cell function, including lymphocyte 
adhesion to high endothelial venules and to the 
extracellular matrix and T cell activation. We now 
demonstrate that triggering of CD44 on T lympho­
cytes by anti~CD44 mAb promotes cell adhesion. 
The induced homotypic adhesion is mediated by 
lymphocyte function-associated antigen-1 (LFA-1), 
because it was inhibited by anti-LFA-1 antibodies 
and not by anti-LFA-3 antibodies. This notion is  
supported by the temperature and Mg2+ dependence 
which is characteristic of LFA-1-mediated adhesion. 
Moreover, the sensitivity of CD44~induced adhesion 
to AMG and H7, which both prevent the activation 
of protein kinase C, and to cytochalasin B, which 
inhibits microfilament formation* suggests that the 
activation of the LFA-1 pathway via CD44 involves 
protein kinase C activation and requires an intact 
cytoskeleton.
Lym phocytes m igrate  from th e  blood to  lym phoid  or­
gans  via specialized HEV3 (1-3). A p r im ary  s te p  in  th is  
m igration process is th e  adhesion  of lym phocytes to  th e  
walls of HEV. T his  step, w hich  is  th o u g h t  to regu la te  th e  
p referen tia l m igration  of lym phocy tes  (i.e., hom ing), is 
m ediated  by in te rac tio n s  be tw een  lym phocyte  cell s u r ­
face m olecules te rm ed  “hom ing re c e p to rs ’* (3-5) a n d  th e ir  
endothelial ligands, so-called “v a s c u la r  add ress in s"  (6, 7). 
Recently, several d is tinc t lym phocy te  hom ing  recep to rs  
were defined by biochem ical s tu d ie s  a n d  m olecu lar c lon ­
ing (8-10).
In h u m a n s ,  an  85 to 95-kDa glycoprotein, th e  H erm es 
Ag, is involved in lym phocyte b in d in g  to HEV (3, 5, 11, 
12). T h is  putative hom ing  recep tor is closely re la ted  to  or 
identical to th e  h u m a n  phagocytic  glycoprotein  Pgp-1,
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th e  blood g roup  Ag In(Lu), a n d  th e  ex trace llu la r  m a tr ix  
recep to r  III, all of w h ic h  fall w ith in  th e  CD44 c lu s te r  ( I S ­
IS). T h e  ex p ress io n  of C D 44 Ag is n o t  re s tr ic ted  to ly m ­
phocy tes; sev e ra l  o th e r  hem atopo ie tic  a n d  n o n h e m a to -  
poietic cells h av e  a lso  b een  reported  to ex p ress  CD44 Ag 
(3, 8, 10, 12). T h e  fu n c t io n  of CD44 m ay  th u s  n o t  be 
lim ited  to  HEV recogn ition  a n d  ad h es io n , b u t  it  m ay  h av e  
a  m u c h  b ro a d e r  role in  th e  biology a n d  pa tho logy  of cell 
ad h es io n . T h is  possib ility  is su p p o r ted  by DNA clon ing  
d a ta  sh o w in g  hom ology to cartilage  link  p ro te in s  (8, 10) 
a n d  by  fu n c t io n a l  s tu d ie s  w h ich  in d ica te  t h a t  CD44 p a r ­
t ic ip a te s  in  h y a lu ro n ic  ac id  (17, 18) a n d  collagen recog­
n ition  (14). In te res ting ly , severa l s tu d ie s  have  im p lica ted  
CD44 a s  a  fa c to r  in  ly m p h o m a  m e ta s ta s is  (3, 19, 20, 21). 
In ad d it io n  to th e  CD 44 Ag, two m e m b e rs  of th e  in te g r in  
fam ily , i.e., th e  lym phocy te  fu n c tio n -asso c ia ted  Ag LFA- 
1 (CD 1 l a /1 8 )  a n d  LPAM-1, m olecules t h a t  p lay  a  role in  
a  w ide v a r ie ty  of cell-cell in te ra c t io n s  (22), have  also  b e e n  
im plica ted  in  lym phocy te  a d h e s io n  to a n d  m igra tion  v ia  
HEV (23, 24).
T h e  fa c t  t h a t  m olecu les  m ed ia tin g  lym phocy te  h o m in g  
a p p a re n t ly  m a y  h a v e  im p o r ta n t  u n re la te d  a d h e s io n  or 
recep to r  fu n c t io n s  a s  well p rom pted  us to  s tu d y  th e  ro le 
of CD 44 in  v a r io u s  cell-cell in te rac tio n s .  Here we re p o r t  
th a t  m A b d irec ted  a g a in s t  CD44 do n o t  in h ib it  but, in  
c o n tra s t ,  s t im u la te  hom otyp ic  T cell in te rac tio n s . O u r  
d a ta  in d ica te  th a t  th e  LFA-1 p a th w a y  is involved in th i s  
C D 44-induced  ad h es io n .
MATERIALS AND METHODS
m Ab and  chem icals. The mAb used were NKI-P1 (IgGl), NKI-P2 
(IgGl), Hermes-3 (IgG2a), and 50B4 (IgG2b), all reactive with CD44 
(5, 17, 25); CLB-LFA-1/1 (IgGl), specific for the /9 subun it of LFA-1 
(26); CLB-LFA-1/2 (IgGl), specific for the c* subun it of LFA-1 (27); 
W 6/32 (IgG2a), specific for a nonpolymorphic de term inan t of HLA- 
ABC (28); R.R1/1 (IgGl), specific for ICAM-1 (29); and TS2/9  (IgGl), 
specific for LFA-3 (30),
The reagents used were PMA (50 ng/ml; Sigma Chemical Co., St. 
Louis, MO); sodium azide (0.1%; Merck, D arm stadt, FRG), an  inh ib ­
itor of oxidative phosphorylation; H7 (20 ^M; Sigma), w hich prevents 
the activation of PKA and  PKC (31); AMG (60 nM; Sigma), which 
prevents the activation of PKC; W7 (20 ¿tM; Sigma), which inhibits 
calm odulin-dependent protein kinase (32); and cytochalasin B (20 
ijM\ Sigma), w hich inhib its  microfilament form ation (33).
Celt lines a n d  cell cu ltures. JY, an EBV-transformed B cell tine, 
was cultured in RPMI 1640 medium w ith 25 mM HEPES buffer 
(GIBCO, Grand Island, NY). T cell lines were cultured in Iscove's 
medium (GIBCO). Both media were routinely supplem ented w ith 1 
mM glutam ine, 10% (vol/vol) heat-inactivated FCS (Hyclone Labo­
ratories Inc., Logan, UT), 100 U of natrium  penicillin G (Gist Brocades 
NV, Delft, The Netherlands) per ml, and  100 U of streptomycin 
sulfate (Pharm achem ie BV, Haarlem, The Netherlands) per ml.
T cell lines were initiated by culturing PBMC isolated from normal 
donors by Ficoll-Isopaque density gradient centrifugation in the 
presence of the anti-CD3 mAb OKT3 (0.01%; Ortho Diagnostic Sys­
tems Inc., Raritan, NJ) and 5% TCGF (34). These cultures were
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restimulated weekly at a concentration of 2 X 10s cells/ml by the 
addition of 1 x 106 3000 rad-irradiated PBMC and  1 X 105 5000 rad- 
irradiated JY cells in  the presence of OKT3 and  5% TCGF. TCGF 
was produced as  follows. PBMC were stim ulated with 0.1 fig of the 
phorbol ester PMA per ml for 2 h a t  37°C (50 x 106 cells/ml of 
medium), w ashed extensively, and  cultured for 48 h in  the presence 
of 15 Mg of Con A (Sigma) per ml. At the end of the incubation period, 
Con A was neutralized by adding 50 mM ^-methyl mannoside (30 
min, 37°C). The su p e rn a tan t w as harvested, filtered (filters from 
Millipore Corp., Bedford, MA), and  stored at —20°C.
The hum an cytolytic alloreactive T cell clone JS  136 used in th is 
study is directed against an  HLA-DRw6 determ inant (35). Cloned T 
cells were cultured in Iscove’s  medium supplem ented with 2% h u ­
m an  serum and stim ulated weekly w ith irradiated allogeneic PBMC 
and  JY cells, PHA (0.2 p.gjml), and IL-2 (50 U/ml). For the aggregation 
assay, T cells were used 4 to 7 days a fte r  stimulation. No residual 
monocytes were p resen t a t th is  time, as determined by FACS analy­
sis.
Aggregation a s s a y . Cells were seeded in 96-well flat-bottomed 
microtiter plates (Nunc-Immuno Plate Maxisorb; GIBCO). Each well 
contained 1 x 105 cells previously w ashed and resuspended in  RPMI 
1640 medium containing 10% FCS and  was incubated for various 
time periods a t 37°C in the absence or presence of mAb. To study 
the m echanism  of CD44-induced cell aggregation, the  cells were 
preincubated with the  various inhibitors of cell metabolism for 15 
min a t 37°C before adding the  mAb. The requirem ent for bivalent 
cations was studied by w ashing  the cells in HBSS without calcium 
and  magnesium (GIBCO) bu t w ith  1 mM EDTA and  2 mg of D-glucose 
per ml. The cells were plated, and  anti~CD44 antibodies were added.
Homotypic aggregation w as m easured in a sem iquantltative m an ­
ner by the method described by Rothlein and Springer (29). Scores 
ranged from 0 to 5, w here 0 indicated th a t  essentially no cells were 
aggregated in clusters; 1 Indicated th a t  <10% of the cells were found 
in clusters; 2 Indicated th a t 10 to 50% of the  cells were found in 
clusters; 3 Indicated th a t  50 to 80% of the cells were found in 
clusters; 4 indicated th a t  >80% of the  cells were found in  small 
aggregates; and  5 indicated th a t >90%  of the  cells were found in 
large, compact clusters. During the  experiments, cell viability, as 
determined by trypan  blue exclusion, w as 90% or more.
RESULTS
CD44 s t im u la te s  h o m o ty p ic  a d h e s io n  o f  T  cells. T  cell 
aggregation s tu d ie s  w ere  perfo rm ed  w ith  anti-CD3- an d  
T C G F-stim ulated  p e r ip h e ra l  blood T cells, w h ich  w ere  
u sed  4  to 7 days  a f te r  s t im u la tio n , a t  a  t im e  a t  w h ich  
th e y  show ed n o  s p o n ta n e o u s  aggregation  (Fig. 1). The 
add ition  of PMA read ily  in d u c e d  th e se  T  cells to  aggre­
gate; th is  aggregation  w a s  n o t  b locked  by an ti-C D 44 mAb. 
In terestingly , however» th e  add ition  of m A b NKI-P1 or 
NKI-P2 to (non-PM A -stim ulated] T  cells in d u c e d  h o m o ­
typ ic  T cell ad h es io n  (Fig. 1). T h e  in d u c tio n  of ad h es io n  
w a s  no t observed w ith  th e  an ti-C D 44 m A b 50B 4 or
t i m e ( h o u r s )
Figure }. Induction of T cell aggregation by PMA and NKI-P2. Aggre­
gation of anti-CD3- and TCGF-stimulated peripheral blood T cells was 
determined after 1, 2, and 4 h of incubation in medium alone (•), medium 
with PMA (A), medium with NKI-P2 (O), or medium with PMA and NKI-P2 
(A). NKI-P2 was added at 5 jug/ml.
H erm es-3, bo th  of w h ich  recognize d ifferen t epitopes on 
th e  CD44 molecule. T h is  failure to induce aggregation did 
n o t  re p re sen t  a dose-response problem due to a  lack of or 
a  low express ion  of re levan t epitopes on th e  activated 
cells or to a low b ind ing  affinity, s ince FACS analysis 
show ed s im ilar b in d in g  for all four anti-CD 44 antibodies. 
Moreover, 10 -fold-higher concen tra tions of 50B4 and 
H erm es-3  w ere still ineffective a t  inducing aggregation. 
Incuba tion  w ith  purified  mouse Ig (data no t shown) or 
w ith  an tibod ies  a g a in s t  LFA -la , LFA-1/3, ICAM-1, LFA-
3, a n d  HLA-ABC also did not induce T  cell aggregation 
(Fig. 2A).
NKI-P1 a n d  NKI-P2 were also found to evoke th e  aggre­
gation  of th e  CTL clone J S  136. Unlike anti-CD3-stimu~ 
la ted  p er iphera l blood T cells, J S  136 w as  also induced 
to  aggregate by th e  anti-CD44 mAb H erm es-3 and  50B4 
(Fig. 2B). F inally , th e  mAb NKI-P1 a n d  NKI-P2 also in­
duced hom otypic adhes ion  of freshly  isolated peripheral 
blood T cells. However, despite the  fac t  t h a t  these  cells 
expressed  levels of CD44 comparable to those  expressed 
by th e  ac tiva ted  T cells and  th e  CTL clone, th is  in terac­
tion  requ ired  long (4 to 18 h) incubation  tim es an d  the 
m A b H erm es-3  a n d  50B4 were ineffective (data not 
shown).
C D 44-induced  hom otyp ic  T  cell a d h e s io n  is energy  
d e p e n d e n t  a n d  requires  an  in tact cy to ske le ton .  Sub­
sequently , we a sse sse d  the  metabolic requ irem en ts  for 
CD 44-induced T  cell aggregation. In these  experiments, 
th e  an ti-C D 44 m A b NKI-P2, being the m ost po ten t indu­
cer of aggregation, w as  used. The addition of sodium 
azide, a n  in h ib ito r  of oxidative phosphorylation , pre­
ven ted  C D 44-induced T cell aggregation (Fig. 3), indicat­
ing t h a t  C D 44-induced cell aggregation is m etabolic en­
ergy dependen t. T h is  notion is supported  by the obser­
vation  th a t  aggregation  could no t be induced a t  4°C (data 
n o t  sh o w n ).
The addition  of cytochalasin B, w h ich  p reven ts  the 
fo rm a tio n  of m icrofilam ents, also blocked CD44-induced 
aggregation. F urtherm ore , AMG and  H7, w h ich  interfere 
w ith  PKC an d  PKA (Fig. 3), an d  W7, w hich  inhibits 
ca lm odu lin -dependen t protein k inase, all were found to 
p rev en t  CD 44-induced cell aggregation. In con trast, cy~ 
clohexim ide, a n  inh ib ito r of protein syn thesis , did not 
a ffec t aggregation (data not shown). Hence, CD44-in- 
duced  cell aggregation requires an  in tac t  cell metabolism 
a n d  cytoskeleton an d  seems to depend on in tracellular 
p ro te in  k in a se  activ ity  bu t no t on protein  syn thesis .
CD44~induced a d h es io n  requires m a g n e s iu m . To
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Figure 2. Induction of T-cell aggregation by several anti-CD44 mAb. 
Aggregation of anti-CD3- and TCGF-stimu lated peripheral blood T cells 
(A) and of the CTL clone JS 136 (B) was assayed in medium alone or in 
medium with anti-HLA-ABC; the anti-CD44 mAb NKI-P1, NKI-P2, 
Hermes-3, or 50B4; anti-LFA-la; anti-LFA-l/?; anti-lCAM-1; or anti-LFA- 
3. All mAb were used at 5 /¿g/ml.
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Figure 3. Metabolic requirement for CD44-induced cell aggregation. 
Aggregation of anti-CD3- and TCGF-stimulated peripheral blood T cells 
was determined after the addition of NKI-P2 at 5 /xg/ml alone (leftmost 
bar) or in combination with AMG, azide, H7, W7, or cytochalasin B (Cyt.B).
RPMIHBSS Co Ca Mg Mg
1mM 5mM 1mM 5mM
Figure 4, Cation requirement for CD44-Induced cell adhesion. Induc­
tion of aggregation of anti-CD3- and TCGF-stimulated peripheral blood T 
cells with NKI-P2 (5 was determined in RPMI 1640 medium, In
HBSS free of calcium and magnesium, or in HBSS with 1 mM calcium, 5 
mM calcium, 1 mM magnesium, or 5 mM magnesium.
study the  cation req u irem en t of C D 44-induced  cell a d h e ­
sion, cells were w a sh e d  in HBSS w ith o u t  ca lc ium  o r 
m agnesium  bu t w ith  1 mM EDTA to rem ove  all r e m a in in g  
b ivalent cations. No aggregation o ccu rred  in  b iv a le n t  c a ­
tion-depleted m edium  (Fig. 4). A ggregation  w a s  com ­
pletely restored by 5 mM m agnesium , w h e re a s  th e  ad d i­
tion of 5 mM calcium  caused only m in im a l  cell agg rega­
tion.
CD 44-tnduced T  cell a d h es io n  is  in h ib i te d  b y  an ti-  
LFA-1 m A b . To fu r th e r  analyze th e  m e c h a n is m  of CD44- 
induced homotypic T cell in te rac tio n s , w e p erfo rm ed  
mAb inhibition s tud ies . In these e x p e r im e n ts ,  p o ten tia l ly  
inhibitory  or control mAb were ad d ed  s im u l ta n e o u s ly  
w ith NKI-P2 to the  T cells. mAb d irec ted  a g a in s t  th e  LFA- 
\a  a n d  LFA-1/S ch a in s  blocked C D 44-induced  aggregation  
of bo th  the  anti-CD 3-stim ulated p e r ip h e ra l  blood T  cells 
and  th e  CTL clone J S  136 (Fig. 5), cell p o p u la t io n s  t h a t  
express  high levels of LFA-1. m A b R .R 1 /1  d irec ted  
aga inst ICAM-1, a  ligand of LFA-1, did n o t  s ig n if ic an tly  
inh ib it th e  aggregation of anti-CD3 -s t im u la te d  p e r ip h e ra l  
blood T cells, a l though  some inh ib ito ry  e ffec t w a s  occa­
sionally observed (Fig. 5A). However, CD44~induced a g ­
gregation of J S  136 w as completely b locked  by m A b 
R.R1/1 (Fig. 5B). T h ese  different e ffec ts  of m A b R .R 1/1  
on aggregation paralle lled  ICAM-1 ex p ress io n  on  th e s e
Figure 5. mAb inhibition studies of CD44-induced cell adhesion. In­
duction of aggregation of anti-CD3- and TCGF-stimulated peripheral 
blood T cells (A) or of the CTL clone JS 136 (B) by NK1-P2 alone (leftmost 
bars) or in combination with anti-LFA-1«, anti-LFA-1/3, anti-ICAM-1, 
anti-LFA-3, or anti-HLA-ABC was studied. All mAb were applied at 5 ng/ 
ml.
t i m e (m¡ n.)
Figure 6. Aggregation and reaggregation kinetics of CD44-induced cell 
clustering. NKI-P2 was added to all cell cultures at the start of the 
experiment. Cells were either allowed to aggregate undisturbed (O) or 
resuspended after 20 min (A), 40 min (A), or 60 min (★). For this experi­
ment, anti-CD3- and TCGF-stimulated peripheral blood T cells were used 
and NKI-P2 was added at 5 /tg/ml.
tw o cell ty p es , an ti-C D 3 -s tim u la ted  p e r ip h e ra l  blood T 
cells a n d  J S  136 cells  h a v in g  low a n d  h igh  levels of ICAM- 
1 ex p re ss io n , respec tive ly  (data n o t  show n). m A b a g a in s t  
LFA-3 a n d  HLA-ABC could n o t  in h ib i t  C D 44-induced  T 
cell aggrega tion  (Fig. 5). Im portan tly , th e  s t im u la t io n  of 
CD44 did n o t  in f lu en ce  th e  cell su r fa c e  levels of LFA-1 
a n d /o r  ICAM-1 in  e i th e r  of th e  cell popu la tions , as  te s ted  
in  FACS d o u b le -s ta in in g  ex p erim en ts .
T cell rea g g reg a tto n  a f te r  d is r u p t io n  o f  C D 4 4 -in d u ced  
a d h e s io n .  T h e  t im e  cou rse  of NK I-P2-induced T  cell a d h e ­
s ion  is s h o w n  in  F igure. 6. D uring  th is  t im e  course, CD44 
w a s  n o t  m o d u la ted  from  th e  cell su rface ,  a s  d e te rm in ed  
by FACS a n a ly s is  (da ta  n o t  show n). In s e p a ra te  cu ltu re s ,  
cells w ere  re s u sp e n d e d  20 , 40, o r 60  m in  a f te r  th e  a d d i­
t io n  of NKI-P2. T h e se  re su sp e n d e d  cells read ily  reag g re ­
g a ted  in  th e  p re se n c e  of NKI-P2, a n d  th e  k in e t ic s  of 
aggregation  a n d  reaggrega tion  w ere  s im ilar.
DISCUSSION
T h e  LFA-1 m olecule  p lays  a  key role in lym phocyte  
ad h e s io n  (22). L ym phocy tes  do n o t  a d h e re  s p o n ta ­
neously , b u t  ac tiv a tio n  of PKC by phorbo l e s te rs  gives 
r ise  to  s tro n g  L F A -1 -d ep en d e n t  ad h es io n , suggesting  th a t  
th e  ac tiv a tio n  of L F A -1 is req u ired  to in d u ce  cell ad h es io n  
(36). R ecently , s t im u la t io n  of th e  fu n c tio n a lly  im p o r ta n t
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CD2 and CD3 su rface  s t ru c tu re s  of T lym phocytes h a s  
been shown to prom ote L FA -1-dependent adhesion  (37, 
38). We now d em o n s tra te  th a t  triggering  of th e  CD44 
molecule also e n h a n c e s  th e  adhesion  of T  lymphocytes. 
The induced adhesion  is m edia ted  by LFA-1 becau se  it 
can  be inhibited by  anti-LFA-1 an tibod ies  b u t  no t by 
anti-LFA-3 antibodies. T h is  notion  is supported  by th e  
Mg2+ and tem p era tu re  dependence  w hich  is ch a ra c te r is ­
tic of LFA-1-mediated adhes ion  (22, 39).
All four anti-CD44 m Ab used in  th is  s tudy  prom oted 
homotypic adhesion  of T  lym phocytes bu t were n o t  
equally effective, a n d  T cells from  d iffe ren t sources  v a r ­
ied in  sensitivity to th e ir  aggregation-inducing effects. 
NKI-P1 and NKI-P2 w ere th e  m ost p o ten t  mAb a n d  i n ­
duced homotypic aggregation  of th e  CTL clone JS  136, 
activated T cells, a n d  n o n s t im u la ted  periphera l blood T 
cells, while Herm es-3 a n d  50B4 only induced th e  aggre­
gation of JS  136. T h is  d ifference  be tw een  th e  anti-CE>44 
mAb did not rep re sen t  a  dose-response  problem  due to a  
lack  of or a low express ion  of re levan t epitopes o n  th e  
cells or to a  low b ind ing  affin ity . P resum ably , it w a s  
related to th e  fac t  t h a t  NKI-P1 a n d  NKI-P2 recognize 
closely related epitopes th a t  a re  k n o w n  to differ fu n c t io n ­
ally from the epitope recognized by Herm es-3 (5, 17).
As m entioned above, th e  d iffe ren t T  cells expressed  
comparable levels of CD44 b u t  w ere n o t  equally sensitive  
to  the  adhesion-prom oting effects  of each  of th e  an ti-  
CD44 mAb. Moreover, th ey  aggregated a t  d ifferen t ra tes . 
T hese  observations m o s t  likely reflect va ria tions  in  th e  
in itial activation s ta te  of th e  cells. Non activated  p e r ip h ­
eral blood T cells an d  cells of th e  alloreactive T cell clone 
J S  136 were th e  least a n d  th e  m ost sensitive  to adhesion  
induction via CD44, respectively , w hile  ac tivated  T cells  
h ad  a n  interm ediate sensitiv ity . Cell adhes ion  w as  t h u s  
m ost markedly s tim u la ted  in  T  cell popu la tions th a t  w ere  
a lready  activated to a  c e r ta in  level. As w ith  these  costi­
m ulatory  effects on T  cell ad h es io n , CD44 h a s  recen tly  
been  found to e n h a n c e  T cell p ro lifera tion  w hen  added  
in  combination w ith  a  subo p tim al concen tra tion  of im ­
mobilized anti-CD3 m A b or s t im u la to ry  co n cen tra tio n s  
of anti-CD2 mAb (40-42). F u r th e rm o re ,  anti-CD44 mAb 
in  combination w ith  s t im u la to ry  anti-CD2 mAb w ere  
found  to enhance  T cell-m onocyte aggregation (42, 43). 
On th e  basis of these  da ta , a  g en e ra l  p ic tu re  em erges in  
w hich  triggering of CD44 in  com bina tion  w ith  o the r  (sub- 
optimal) T cell s tim u la to ry  s igna ls  c an  provide th e  in itial 
s tep  in T cell adhesion  a n d  activation . Once a  ce rta in  
level of activation h a s  b een  reached , s t im u la tion  of CD44 
alone, either by mAb or by b in d in g  to a  ligand, fu r th e r  
ac tiva tes  T cells a n d  e n h a n c e s  T cell adhesion . T h is  
sequence of events could h av e  im p o r ta n t  im plications fo r  
th e  pathogenesis of ch ron ic  in f lam m ato ry  d iseases, su c h  
a s  rheumatoid a r th r it is ,  in  w h ich  CD44 molecules on 
(pre)activated T cells in te ra c t  w ith  HEV a n d  ex trace llu la r  
m a tr ix  constituen ts  in  th e  in f lam ed  synovium . T h ese  
in te rac tions  via CD44 would in c rease  T cell adhesion  an d  
activa tion  and, consequently , m igh t e n h a n c e  a n d  p e rp e t­
u a te  the  inflam m atory  re sp o n se . In th is  context, th e  r e ­
c e n t  finding th a t  hya lu ron ic  acid, a m ajor co n s ti tu en t  of 
th e  extracellular m atr ix  of connec tive  t is su e s  a n d  ca r t i ­
lage, is a  ligand of CD44 is of g rea t  in te re s t  (17, 18).
How does the  triggering  of CD44 ac tiva te  th e  LFA-1 
p a th w ay ?  Although th e  p re s e n t  d a ta  c a n n o t  definitively 
a n s w e r  th is  question, th e  f in d in g  th a t  bo th  AMG, w hich  
selectively prevents th e  ac tiv a tio n  of PKC, a n d  H7, w h ich
preven ts  th e  activation  of both  PKC a n d  PKA, effectively 
inh ib ited  th e  aggregation-promoting effect of anti-CD44 
suggests a n  im p o rtan t  role for PKC-dependent m echa­
n ism s. PKC activated via CD44 m ight ac tivate  LFA-1 by 
d irec t phosphorylation  of the  /0-chain or, alternatively, by 
phosphoryla tion  of a  cytoskeletal p ro te in  such  as talin, 
w h ich  m ight th e n  b in d  a n d  activate LFA-1 (44). F u rth e r­
m ore, the  fact th a t  cy tochalasin  B, a n  inh ib ito r  of micro­
filam ents , blocked CD44-induced cell aggregation indi­
ca te s  th a t  the  connection  of CD44 a n d /o r  LFA-1 to the 
cytoskeleton (36, 45) is im portan t to i ts  function  in cell 
activation. Alternatively, th e  induction  of adhesion  by 
anti-CD44 antibodies m ight resu lt from  a  direct in te rac­
tion  of CD44 and  LFA-1, leading to a  conformational 
change  in th e  LFA-1 molecule, as h a s  been  suggested for 
th e  induction of adhesion  by the  anti-LFA-1 mAb NKI- 
L16 (46).
CD44-induced cell aggregation of th e  CTL clone JS  136 
w a s  blocked by anti-ICAM-1. However, anti-ICAM-1 did 
n o t  block th e  CD44-induced aggregation of anti-CD3- 
s tim ula ted  periphera l blood T cells. T hese  differences in 
b locking  effects parallelled a  d ifference in  ICAM-1 
expression  betw een th e  two cell types, J S  136 and  anti- 
CD 3-stim ulated periphera l blood T cells, hav ing  high and 
low levels of ICAM-1 expression, respectively. It is possi­
ble t h a t  the  adhesion  of anti-CD 3-stim ulated peripheral 
blood T cells is largely mediated th rough  a n  interaction 
of LFA-1 w ith  a  ligand d istinct from  ICAM-1. Consistent 
w i th  our observation, several LFA-1-mediated adhesion 
p h en o m en a  involving activated lym phocytes have also 
b e e n  described to be ICAM-1 independen t (47, 48).
CD44-triggered adhesion  w as pers is ten t, because cells 
readily  reaggregated a f te r  disruption of th e  aggregates. 
R ecently , s tudies of CD2- and  CD3-induced cell adhesion 
(37, 38) have revealed th a t  enhanced  adhesion  induced 
by  CD2 is also pers is ten t. In con trast, triggering of CD3 
only trans ien tly  prom otes T cell adhesion. Although fu r­
th e r  s tudies are needed to clarify these  differences be­
tw een  CD44- an d  CD2-triggered adhesion  versus CD3- 
in d u ced  adhesion, th e  fac t th a t  anti-CD3 mAb are readily 
m odu la ted  from  th e  cell surface, w hereas  anti-CD2 mAb 
a n d  anti-CD44 mAb rem a in  present, suggests th a t  differ­
e n c e s  in the k inetics of receptor tu rnover play a  role.
In conclusion, our d a ta  indicate th a t  triggering of CD44 
c a n  induce T  cell aggregation via th e  LFA-1 pathway. 
However, in o ther system s, different adhesion  pathw ays 
m ig h t  be activated th ro u g h  CD44, since D enning  et al.
(40) a n d  Haynes et al. (13) have recently  provided evi­
d en ce  th a t  antibodies ag a in s t  CD44 inc rease  T cell-mon­
ocyte b inding  via CD2-LFA-3. Furtherm ore , we have 
observed  th a t  T cell c lones from an  LFA-1-deficient p a ­
t ie n t  can  also be induced to aggregate via CD44 (our 
u n p u b lish ed  observation). This LFA-1-independent 
ad h es io n , w h ich  does not require ca tions or metabolic 
energy, probably involves CD2-LFA-3 or direct binding 
of CD44 to (one of) its ligands (14, 17, 18).
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